• Join
  • Contact
  • Shopping Cart Shopping Cart
    0Shopping Cart
Medical Affairs Professional Society
  • Membership
    • Join MAPS
    • Access your Member Profile
    • Membership FAQ
  • Professional Development
    • MSL Training Camp
    • Online Courses
    • Knowledge Center
      • Standards & Guidance
      • Position Papers
      • White Papers
      • Benchmark Reports
      • Webinars
      • Elevate Articles
      • Elevate Podcasts
      • Innovate Articles
    • Textbook
  • MasterClass
    • MasterClass
    • MasterClass Onsite
  • Partnerships
    • Industry Partnership Program
    • Partner Circle Program
    • Media Planner
  • Meetings & Events
    • What are MAPS Meetings?
    • 2026 Americas Meetings
    • MAPA-MAPS Sydney Summit 2025
  • Opportunities
    • Focus Area Working Groups
    • Awards
    • Chapters
    • Get Involved
    • Mentorship Program
    • Job Postings
  • About
    • Mission, Vision & Value
    • Leadership
    • Career Resources
    • Our Team
    • Policies
    • Bylaws
  • Menu Menu
  • Link to LinkedIn
  • Link to X
  • Link to Instagram

Authors:

Daniel Ng, PharmD, MBA, Senior Director, Head of HEOR, International Markets and Greater China, Astellas Pharma Global Development, Astellas

Hidecki Maeda, PhD, Professor, Department of Regulatory Science, Meiji Pharmaceutical University

Interviewees:

Korea: Dong-Churl Suh, RPh, MBA, PhD, Professor and Director, College of Pharmacy, Chung-Ang University, Seoul, South Korea

China: Jianwei Xuan, Professor and Director, Health Economics Research Institute, Sun Yat-sen University, Guangzhou, China

This publication represents the consensus opinions of the authors and various members of MAPS but does not represent formal endorsement of conclusions by their organizations. 

 

Introduction

There is growing interest globally in using real-world data (RWD) and real-world evidence (RWE) for applications including regulatory decisions, health technology assessment (HTA), pharmacovigilance and more. However, Asia currently lacks a framework to effectively collect and utilize a broad range of RWD/RWE[1]. This gap presents Medical Affairs teams with significant opportunity to lead the collection, dissemination and adoption of learnings based on RWE, especially in light of significant market size and burden of diseases such as stroke and ischemic heart disease, which have been the focus on much pharmaceutical development in the West. The objective of this interview-based article is to detail the current state of RWE use in China and Korea and explore what the future evolution will be for its use.

Download the Complete Paper

Members: Login to Access this Content Non-Members: Buy Here

Search Search
MAPS LinkedIn

Elevate Podcast Channel

Popular
  • Why Good Science is Good Business: A Conversation with Murali...October 15, 2020 - 12:05 PM
  • Navigating The Storm Episode 1: Crisis Management – A...August 26, 2025 - 8:57 AM
  • Best Practices for Managing the Life Cycle of an Investigator-Initiated...May 4, 2018 - 10:44 AM
  • Now More Than Ever, HEOR Plays a Central Role in Forging...June 24, 2018 - 10:51 AM
  • Compliance Considerations in Medical/Commercial Collabo...August 30, 2018 - 10:35 AM
  • Medical Affairs Excellence and Ethics & Compliance...August 30, 2018 - 10:41 AM

Connect with Us

602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073

© 2025 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.

Follow Us
  • Link to X
  • Link to LinkedIn
  • Link to Instagram
Subscribe to MAPS Newsletter
MAPS Program Support Services
Policies and Positions
Link to: Leadership Perspectives – The Impact of Digital on Healthcare Link to: Leadership Perspectives – The Impact of Digital on Healthcare Leadership Perspectives – The Impact of Digital on Healthcare Link to: The Power of the Empowered MSL Link to: The Power of the Empowered MSL The Power of the Empowered MSLThe Power of the Empowered MSL
Scroll to top Scroll to top Scroll to top
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}